SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-071070
Filing Date
2024-06-13
Accepted
2024-06-13 08:05:25
Documents
15
Period of Report
2024-06-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417144d1_8k.htm   iXBRL 8-K 22753
2 EXHIBIT 99.1 tm2417144d1_ex99-1.htm EX-99.1 66032
6 GRAPHIC tm2417144d1_ex99-1img001.jpg GRAPHIC 19440
  Complete submission text file 0001104659-24-071070.txt   299616

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA coll-20240613.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20240613_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20240613_pre.xml EX-101.PRE 22373
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2417144d1_8k_htm.xml XML 3700
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 241040049
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)